Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 0.00 (-13.33%)
As of: Oct 21, 2026 · 12:27 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Enterprise Value (2015 - 2025)

Updated

Adaptimmune Therapeutics' Enterprise Value came in at $355.57 million for Q2 2025, down 72.4% from $1.29 billion a year earlier but up 37.6% from the prior quarter.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Enterprise Value (2015 - 2025) Analysis & Trends

Over the trailing twelve months to Jun 30, 2025, Adaptimmune Therapeutics reported Enterprise Value of -$41.68 million; for FY2024, it came in at $677.65 million, down 27.1% from FY2023.

  • Enterprise Value has declined in each of the last four years, though with a five-year compound annual growth rate of 0.3% (FY2019 to FY2024).
  • Going back by year, Enterprise Value was $929.84 million in FY2023 (-24.8%), $1.24 billion in FY2022 (-60.7%), $3.15 billion in FY2021 (-32.2%) and $4.64 billion in FY2020 (+594.6%).
  • The five-year range for quarterly Enterprise Value is $258.5 million (Q1 2025) to $7.01 billion (Q3 2020).
  • Year-over-year, Enterprise Value has declined for three consecutive quarters, with growth averaging 4.6% over the last eight quarters.
  • The fastest year-over-year change in Enterprise Value over five years came in Q3 2020 (growth of 724.9%), and the weakest in Q1 2025 (a decline of 88.7%).
  • Business Quant data shows ADAPY's Enterprise Value at $258.5 million (Q1 2025), $677.65 million (Q4 2024) and $1.27 billion (Q3 2024) in the three quarters before Q2 2025.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 355.57 Mn
Mar 31, 2025 258.50 Mn
Dec 31, 2024 677.65 Mn
Sep 30, 2024 1.27 Bn
Jun 30, 2024 1.29 Bn
Mar 31, 2024 2.28 Bn
Dec 31, 2023 929.84 Mn
Sep 30, 2023 901.20 Mn
Jun 30, 2023 825.89 Mn
Mar 31, 2023 918.14 Mn
Dec 31, 2022 1.24 Bn
Sep 30, 2022 861.94 Mn
Jun 30, 2022 1.41 Bn
Mar 31, 2022 1.70 Bn
Dec 31, 2021 3.15 Bn
Sep 30, 2021 4.61 Bn
Jun 30, 2021 3.70 Bn
Mar 31, 2021 4.64 Bn
Dec 31, 2020 4.64 Bn
Sep 30, 2020 7.01 Bn
API Access

Adaptimmune Therapeutics PLC Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=ADAPY&period=max&api_key=YOUR_API_KEY